Cargando…

Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda

Worldwide, Drug-resistant Tuberculosis (DR-TB) remains a big problem; the diagnostic capacity has superseded the clinical management capacity thereby causing ethical challenges. In Sub-Saharan Africa, treatment is either inadequate or lacking and some diagnosed patients are on treatment waiting list...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasozi, Samuel, Kirirabwa, Nicholas Sebuliba, Kimuli, Derrick, Luwaga, Henry, Kizito, Enock, Turyahabwe, Stavia, Lukoye, Deus, Byaruhanga, Raymond, Chen, Lisa, Suarez, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772013/ https://www.ncbi.nlm.nih.gov/pubmed/33373997 http://dx.doi.org/10.1371/journal.pone.0244451

Ejemplares similares

A four-year trend in pulmonary bacteriologically confirmed tuberculosis case detection in Kampala-Uganda
por: Kirirabwa, Nicholas Sebuliba, et al.
Publicado: (2019)

Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda
por: Kirirabwa, Nicholas Sebuliba, et al.
Publicado: (2018)

Unsuppressed viral load after intensive adherence counselling in rural eastern Uganda; a case of Kamuli district, Uganda
por: Ndikabona, Geoffrey, et al.
Publicado: (2021)

Trend and outcome of notified children with tuberculosis during 2011-2015 in Kampala, Uganda
por: Wobudeya, Eric, et al.
Publicado: (2017)

Evaluation of Xpert(®) MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Community-based directly observed therapy is effective and results in better treatment outcomes for patients with multi-drug resistant tuberculosis in Uganda
por: Makabayi-Mugabe, Rita, et al.
Publicado: (2023)

Tuberculosis yield among contacts of non-pulmonary bacteriologically confirmed index TB patients in the urban setting of central Uganda
por: Kisamba, Herbert, et al.
Publicado: (2022)

Impact of socio-economic factors on Tuberculosis treatment outcomes in north-eastern Uganda: a mixed methods study
por: Nidoi, Jasper, et al.
Publicado: (2021)

Developing a patient-centered community-based model for management of multi-drug resistant tuberculosis in Uganda: a discrete choice experiment
por: Makabayi-Mugabe, Rita, et al.
Publicado: (2022)

Tuberculosis Preventive Therapy among Persons Living with HIV, Uganda, 2016–2022
por: Lukoye, Deus, et al.
Publicado: (2023)

Implementation science to improve the quality of tuberculosis diagnostic services in Uganda
por: Cattamanchi, Adithya, et al.
Publicado: (2019)

Factors associated with poor treatment outcomes among tuberculosis patients in Kyangwali Refugee Settlement, Uganda, 2016–2017
por: Nguna, Joyce, et al.
Publicado: (2022)

Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study
por: Kizito, Enock, et al.
Publicado: (2021)

Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study
por: Leddy, Anna, et al.
Publicado: (2023)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

A user-centred implementation strategy for tuberculosis contact investigation in Uganda: protocol for a stepped-wedge, cluster-randomised trial
por: Katamba, Achilles, et al.
Publicado: (2023)

A user-centred implementation strategy for tuberculosis contact investigation in Uganda: Protocol for a stepped-wedge, cluster-randomised trial
por: Katamba, Achilles, et al.
Publicado: (2023)

Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013–2017
por: Okethwangu, Denis, et al.
Publicado: (2019)

Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014–2018
por: Bahizi, Gloria, et al.
Publicado: (2021)

Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study
por: Baluku, Joseph Baruch, et al.
Publicado: (2021)

Variation in tuberculosis treatment outcomes and treatment supervision practices in Uganda
por: Berger, Christopher A., et al.
Publicado: (2020)

The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
por: Ezati, Nicholas, et al.
Publicado: (2014)

Correction: Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study
por: Baluku, Joseph Baruch, et al.
Publicado: (2023)

Uganda Public Health Fellowship Program's Contributions to the National HIV and TB Programs, 2015–2020
por: Ario, Alex R., et al.
Publicado: (2022)

Video directly observed therapy for supporting and monitoring adherence to tuberculosis treatment in Uganda: a pilot cohort study
por: Sekandi, Juliet N., et al.
Publicado: (2020)

Multidisciplinary management of difficult-to-treat drug resistant tuberculosis: a review of cases presented to the national consilium in Uganda
por: Baluku, Joseph Baruch, et al.
Publicado: (2021)

Low level of tuberculosis preventive therapy incompletion among people living with Human Immunodeficiency Virus in eastern Uganda: A retrospective data review
por: Lwevola, Paul, et al.
Publicado: (2021)

Epidemiology of tuberculosis in children in Kampala district, Uganda, 2009–2010; a retrospective cross-sectional study
por: Wobudeya, Eric, et al.
Publicado: (2015)

Households experiencing catastrophic costs due to tuberculosis in Uganda: magnitude and cost drivers
por: Muttamba, Winters, et al.
Publicado: (2020)

Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2016)

Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis
por: Thompson, Ryan R, et al.
Publicado: (2023)

Integration of COVID-19 and TB screening in Kampala, Uganda - Healthcare provider perspectives
por: Semitala, Fred C, et al.
Publicado: (2022)

Integration of COVID-19 and TB screening in Kampala, Uganda: healthcare provider perspectives
por: Semitala, Fred C., et al.
Publicado: (2023)

Rates of Anti-Tuberculosis Drug Resistance in Kampala-Uganda Are Low and Not Associated with HIV Infection
por: Lukoye, Deus, et al.
Publicado: (2011)

Integrating interferon-gamma release assay testing into provision of tuberculosis preventive therapy is feasible in a tuberculosis high burden resource-limited setting: A mixed methods study
por: Muchuro, Simon, et al.
Publicado: (2022)

Comparative yield of different active TB case finding interventions in a large urban TB project in central Uganda: a descriptive study
por: Kazibwe, Andrew, et al.
Publicado: (2021)

Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda
por: Samuels, Thomas H. A., et al.
Publicado: (2021)

Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda
por: Cattamanchi, Adithya, et al.
Publicado: (2021)

Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda
por: Kigozi, Edgar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dnh6fcb3gnbb1edcc1as0ia8cq